In this article, we discuss the 5 best very cheap stocks to buy right now. If you want to read our detailed analysis of these stocks, go directly to the 15 Best Very Cheap Stocks to Buy Right Now.
5. Wipro Limited (NYSE: WIT)
Number of Hedge Fund Holders: 13
Price as of June 25: $7.83
Wipro Limited (NYSE: WIT) ranks 5th on the list of 15 best very cheap stocks to buy right now. The IT company was founded in 1945 and is headquartered in Bengaluru, India. Wipro Limited is one of the leading providers of IT consulting services in the world. The company also develops innovative tech solutions in robotics, cognitive computing, analytics, cybersecurity, and cloud computing. Wipro Limited (NYSE: WIT) is one of the best cheap stocks to buy right now as the company pays an annualized dividend of $0.012 per share to shareholders. The stock’s dividend yield is 0.17%.
The company has a market cap of $41 billion. The stock has offered investors returns exceeding 163% over the past twelve months. Shares of WIT are also up 12% in the last month. The company’s gross revenue in 2020 increased by 1.53.4% to $8.5 billion year-over-year. Among the company’s partners are Adobe Inc. (NASDAQ: ADBE), Cisco Systems, Inc. (NASDAQ: CSCO), and Microsoft Corporation (NASDAQ: MSFT). In March, the company announced its acquisition of a multinational management and tech consultancy firm Capco for $1.45 billion. On May 26, Bernstein upgraded Wipro Limited to Market Perform, with a price target of $6.2 per share.
There were 13 hedge funds that reported owning stakes in Wipro Limited (NYSE: WIT) at the end of the first quarter, up from 11 funds a quarter earlier. The total value of these stakes at the end of Q1 is $130 million.
4. Amneal Pharmaceuticals, Inc. (NYSE: AMRX)
Number of Hedge Fund Holders: 15
Price as of June 25: $5.34
Amneal Pharmaceuticals, Inc. (NYSE: AMRX) ranks 4th on the list of 15 best very cheap stocks to buy right now. The New Jersey-based pharmaceutical company was established in 2002 and has since evolved into one of the most dynamic generic medicine manufacturers in the United States. The pharmaceutical company provides generic treatment medicines and products ranging from injectables and inhalants to pharmaceuticals for central nervous system diseases. The company also distributes medical and surgical products to governmental agencies. Amneal Pharmaceuticals, Inc. sells its medical products in the US and Puerto Rico.
The company has a market cap of $886 million. Shares of AMRX increased 33% over the past twelve months. The company’s revenue in the first quarter of 2021 decreased 1% to $493 million, down from $499 million in the first quarter of 2020 due to lower influenza activity in the first quarter of 2021. The company posted a net income of $7 million or $0.04 diluted income per share. On March 3, Goldman Sachs upgraded Amneal Pharmaceuticals, Inc. to a Buy rating, with a price target of $6.5 per share.
There were 15 hedge funds that reported owning stakes in Amneal Pharmaceuticals, Inc. (NYSE: AMRX) at the end of the first quarter, up from 8 funds a quarter earlier. The total value of these stakes at the end of Q1 is $77.5 million.
3. Endo International plc (NASDAQ: ENDP)
Number of Hedge Fund Holders: 17
Price as of June 25: $4.92
Endo International plc (NASDAQ: ENDP) ranks 3rd on the list of 15 best very cheap stocks to buy right now. The Dublin-based pharmaceutical company produces branded and generic medicines treatments for pain, endocrinology, urology, and orthopaedic management. The company has a portfolio of 135 generic pharmaceutical products including nasal sprays and ophthalmic products. On top of that, Endo International plc markets cancer and transplantation pharmaceutical products.
The company has a market cap of $1.5 billion. The stock has offered investors returns exceeding 83% over the past twelve months. Shares of ENDP are also up 12% in the last month. First-quarter revenue decreased by 12% to $717,919, down from $820,405 in the same period in 2020. As of March 31, 2021, the company’s total assets are $9.2 million versus its total current liabilities of $1.4 million. On March 3, Morgan Stanley maintained an Underweight rating on Endo International plc, with a price target of $7 per share. The stock has a PE ratio of 15.42.
There were 17 hedge funds that reported owning stakes in Endo International plc (NASDAQ: ENDP) at the end of the first quarter, up from 13 funds a quarter earlier. The total value of these stakes at the end of Q1 is $406 million.
2. Infinera Corporation (NASDAQ: INFN)
Number of Hedge Fund Holders: 20
Price as of June 25: $10.64
Infinera Corporation (NASDAQ: INFN) ranks 2nd on the list of 15 best very cheap stocks to buy right now. The California-based telecommunications firm develops cutting-edge technology and innovative solutions for network automation, 5G deployment, cloud networking, and open optical networking. Infinera Corporation (NASDAQ: INFN) serves more than 500 customers in over 100 countries.
The company has a market cap of $2.2 billion. The stock has offered investors returns exceeding 106% over the past twelve months. Shares of INFN are also up 22% in the last month. The company’s revenue in the first quarter of 2021 came in at $330,907. As of March 27, 2021, Infinera Corporation’s total assets were $1.6 million versus its total current liabilities of $505,928. On May 13, Wolfe Research upgraded its rating on Infinera Corporation to Peer Perform, with a price target of $10 per share.
There were 20 hedge funds that reported owning stakes in Infinera Corporation (NASDAQ: INFN) at the end of the first quarter. The total value of these stakes at the end of Q1 is $373 million.
1. Nokia Corporation (NYSE: NOK)
Number of Hedge Fund Holders: 21
Price as of June 25: $5.47
Topping the list of 15 best very cheap stocks to buy right now is Nokia Corporation (NYSE: NOK). The Finland-based telecommunications and consumer electronics company was founded in 1865 and has grown to become one of the world’s largest mobile phone manufacturers. In recent years, the company has moved its attention away from mobile phone production and toward the rapidly expanding 5G technology infrastructure and equipment.
The company has a market cap of $31 billion. The stock has offered investors returns exceeding 29% over the past twelve months. Shares of NOK are also up 11% in the last month. The company’s revenue in the first quarter of 2021 came in at $6.2 billion, up 3% from $5.9 billion in the first quarter of 2020. The technology firm reported $0.08 EPS for the quarter, $0.07 higher than analysts’ expectations of $0.01. Nokia Corporation adjusted its revenue outlook for the fiscal year 2021 from $25 billion to $26.4 billion. On May 7, Morgan Stanley upgraded its rating on Nokia Corporation from Equal-Weight to Overweight. As of June 11, Nokia Corporation’s (NYSE: NOK) forward PE ratio is 18.65 while its price to sales ratio is 1.191.
There were 21 hedge funds that reported owning stakes in Nokia Corporation (NYSE: NOK) at the end of the first quarter, up from 19 funds a quarter earlier. The total value of these stakes at the end of Q1 is $353 million.
You can also take a peek at 10 Best Tech Stocks to Buy According to Billionaire Julian Robertson and Top Chinese Companies on NASDAQ.
